Source: Kapitales Research

With healthcare innovation, stronger bank capital positions, elevated gold prices and rising defence spending continuing to shape market sentiment, will these themes remain the key drivers of ASX leadership in the weeks ahead?Highlights:

• SimonMed deal sparks fresh optimism around 4DMedical’s US expansion.
• Judo’s capital move strengthens growth capacity; investors eye next steps.
• Gold and defence names surge as macro themes continue gaining traction.

Market Movers Snapshot

• 4DMedical Limited (ASX: 4DX) gained ~10.93% to AU$3.705.
• Judo Capital Holdings Limited (ASX: JDO) advanced ~8.88% to AU$1.512.
• West African Resources Limited (ASX: WAF) climbed ~7.14% to AU$3.150.
• Westgold Resources Limited (ASX: WGX) rose ~7.00% to AU$5.210.
• DroneShield Limited (ASX: DRO) increased ~6.90% to AU$3.410.

Health Tech Momentum4DMedical was the session’s top performer after securing a commercial agreement with SimonMed Imaging, a leading US outpatient imaging provider. The deal will deploy CT:VQ™ and LDAf™ technologies across more than 170 imaging centres in 10 states, enabling immediate commercial use. Investors welcomed the expansion, viewing it as a step toward broader adoption, reimbursement support, and future revenue growth.Capital Strength BoostedJudo Capital advanced after announcing a AU$750 million capital-relief securitisation backed by SME business loans, exceeding its initial AU$500 million target due to strong investor demand. The transaction is anticipated to strengthen the bank’s capital position, lifting its pro forma CET1 ratio from 12.6% to 13.2%, while also supporting a gradual improvement in return on equity over the longer term. Investors welcomed the stronger capital position and capacity to support future lending growth.Gold Stocks ShineGold mining stocks featured among the market’s strongest performers as gold prices remained near record highs. Gold traded around US$4,519 per ounce, supported by persistent inflation concerns and ongoing geopolitical uncertainty despite reports of diplomatic progress between the United States and Iran.West African Resources benefited from the favourable gold price environment, with stronger bullion prices enhancing sentiment toward gold producers and supporting investor interest in the sector.Westgold Resources also advanced, aided by elevated gold prices and its ongoing on-market share buy-back program. The company’s continued share repurchases as part of its capital management strategy strengthened investor confidence and reinforced positive sentiment toward the stock.Defence Technology DemandDroneShield continued its strong run after highlighting record FY2025 revenue of AU$216.5 million and rising global demand for counter-drone technologies at its annual general meeting. The company also reported strong FY2026 momentum, with AU$74 million in first-quarter revenue and record customer cash receipts. Investors remained encouraged by expanding opportunities across defence, government, and commercial markets amid increasing global defence spending.Outlook and Market ImplicationsThe day’s strongest performers reflected several powerful themes currently influencing Australian equities: healthcare innovation, financial sector capital optimisation, resilient gold prices and rising global defence spending. While each company operates in a different industry, all benefited from catalysts that highlighted growth opportunities beyond short-term market fluctuations.Looking ahead, investors are likely to remain focused on companies demonstrating clear execution, expanding addressable markets and strong strategic positioning. If gold prices remain elevated and defence expenditure continues rising globally, miners and defence technology providers could remain key areas of market interest, while healthcare and financial innovators may continue attracting attention through commercial and operational milestones.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au